In recent years, Indonesia has embarked on an ambitious journey to transform its healthcare system, aiming to address 5 major diseases like cancer, heart disease, stroke, uronephrology, and maternal and child health. Spearheading this transformation are three major government projects: SIHREN (Strengthening Indonesia's HealthCare Referral Network), SOPHI (Strengthening of Primary Healthcare in Indonesia), and INPULS (Indonesia-Public Laboratory System Strengthening). These initiatives not only aim to enhance healthcare services but also present significant opportunities for medical device manufacturers and regulatory consultants.


Overview of the Mega Projects:

  1. SIHREN (Strengthening Indonesia's HealthCare Referral Network):
  • SIHREN focuses on improving the referral system within Indonesia's healthcare network, ensuring seamless transitions between primary, secondary, and tertiary healthcare facilities.
  • The project aims to enhance access to specialized care, reduce wait times, and improve overall healthcare outcomes for patients.
  1. SOPHI (Strengthening of Primary Healthcare in Indonesia):
  • SOPHI is geared towards bolstering primary healthcare services across Indonesia, with a focus on preventive care, health education, and community engagement.
  • SOPHI aims to reduce the burden on secondary and tertiary care institutions, ultimately improving the overall health of the population.
  1. INPULS (Indonesia-Public Laboratory System Strengthening):
  • INPULS aims to enhance Indonesia's public laboratory system, particularly in the areas of testing, diagnostics, and disease surveillance.
  • The project seeks to improve the quality and reliability of laboratory services, ensuring timely and accurate diagnosis of diseases.

Project Timeline and Budget:

  • Total project value is around US$4 billion.
  • Timeline January 2024 - December 2028.

Insight into Indonesia's Medical Device Market:
The Indonesian medical device market is poised for significant growth due to transformative mega projects, increasing demand for innovative healthcare technologies, and opportunities in disease-specific devices, with regulatory consultants playing a key role in market access.

 

 

Reference:

Teilen: